Skip to content

Press Releases


Filter Releases
 
Press Releases
Date Title and Summary View
Nov 7, 2001
PLAINSBORO, N.J., Nov 7, 2001 (BUSINESS WIRE) --Operating Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $5.4 Million Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported record revenues and net income for the third quarter of 2001. Pro fo...
Oct 31, 2001
PLAINSBORO, N.J., Oct 31, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has scheduled a conference call for 9:00 AM EST on Wednesday, November 7, 2001 to discuss financial results for the third quarter ended September 30, 2001 and to provide forward-looking earnings guidance. Financial r...
Oct 18, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 18, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the Techvest 3rd Annual Conference on Tissue Repair, Replacement and Regeneration on Wednesday, October 24, 2001 beginning at 10:50 AM EDT. The presentation will be...
Oct 17, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 17, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that the United States District Court for the Southern District of California entered orders in favor of the plaintiffs and against Merck KGaA on the final post-judgment motions in the case of Integra LifeSciences ...
Oct 1, 2001
PLAINSBORO, N.J., Oct 1, 2001 (BUSINESS WIRE) -- Integra NeuroSciences, the neurosurgical device division of Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced that it is launching a variety of new products at the Congress of Neurological Surgeons meeting in San Diego, California this week. The followin
Sep 24, 2001
PLAINSBORO, N.J., Sep 24, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has scheduled a conference call for Tuesday, October 2, 2001 at 8:30 AM EST to provide an update to the Company's financial guidance for the remainder of 2001 and for the years 2002 and 2003. This conference ca...
Aug 23, 2001
PLAINSBORO, N.J., Aug 23, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has repaid in full $7.9 million of bank loans and terminated its $4.0 million revolving credit facility with Fleet Capital Corporation. In connection with the prepayment of the loans and the termination of the c...
Aug 15, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 15, 2001--Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced today that it has scheduled an Investor Forum at the Congress of Neurological Surgeons meeting on Tuesday, October 2, 2001 at 7:30 AM Pacific Time at the Radisson Hotel Harbor View in San Diego, California. ...
Aug 13, 2001
PLAINSBORO, N.J., Aug 13, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has closed its public offering of 5,060,000 shares of common stock at $25.50 per share, including 660,000 shares for which the underwriters exercised their over-allotment option. Of the 5,060,000 shares, 4,747,5...
Aug 9, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 9, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has priced a public offering of 5,060,000 shares of common stock at $25.50 per share, including 660,000 shares for which the underwriters exercised their over-allotment option. Of the 5,060,000 shares, 4,747...
Aug 2, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 2, 2001-- Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $4.7 Million Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues and net income for th...
Jul 23, 2001
PLAINSBORO, N.J., Jul 23, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has rescheduled its conference call to discuss financial results for the second quarter ended June 30, 2001 and to update forward looking guidance for the remainder of 2001 and the years 2002 and 2003. The conference...
Jul 20, 2001
PLAINSBORO, N.J.--(BUSINESS WIRE)--July 20, 2001--Integra LifeSciences Holdings Corporation (NASDAQ: IART) today announced that it had filed an amendment to its registration statement on Form S-3 with the Securities and Exchange Commission for a proposed underwritten offering of 3,750,000 shares of Integra common stock, plus an additi...
Jul 5, 2001
PLAINSBORO, N.J., Jul 5, 2001 (BUSINESS WIRE) --Product Launch to Begin in Fourth Quarter Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has received 510(k) clearance from the FDA to market the NeuraGen™ Nerve Guide, an absorbable implant for the repair of severed peripheral nerves in the ex...
Jun 27, 2001
PLAINSBORO, N.J., Jun 27, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the successful completion of a second period of funding for the development of tyrosine-derived polycarbonates. Funded by a three-year grant from the National Institute of Standards and Technology's Advanced Technology ...
= add release to Briefcase